Material Information- Announcement of the Board’s Resolution to release the non-competition restriction on managerial officers
1.Date of the board of directors resolution:2026/11/05
2.Name and title of the managerial officer with permission to engage in competitive conduct: Qiao Li/ Chief Operating Officer of the subsidiary
3.Items of competitive conduct in which the officer is permitted to engage: Representative of the Corporate Director of Handa Pharma, Inc.
4.Period of permission to engage in the competitive conduct: During the tenure as a managerial officer of the Company
5.Circumstances of the resolution (please describe the results of voting in accordance with Article 32 of the Company Act): This proposal is approved by all of the Directors presented at the meeting.
6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the managerial officer (if it is not the operator of a mainland China enterprise, please enter “N/A” below):NA
7.Company name of the mainland China enterprise and the officer’s position in the enterprise: NA
8.Address of the mainland China enterprise: NA
9.Operations of the mainland China enterprise: NA
10.Impact on the company’s finance and business: None
11.If the managerial officer or director has invested in the mainland China enterprise, the monetary amount of the investment and the officer or director’s shareholding ratio: NA
12.Any other matters that need to be specified: None